United States · Who invested in 858 Therapeutics?
858 Therapeutics's investors include New Enterprise Associates, Insight Partners, Versant Ventures, Cormorant Asset Management and Alexandria Venture Investments.
United States · Series B startup
Who invested in 858 Therapeutics
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2024, from 1 source
- Latest round
- Series B, $50MSept 2024
- Investors
- 5
The rounds
- Sept 2024Series B$50M
New Enterprise Associates
Insight Partners
Versant Ventures
Cormorant Asset Management- Alexandria Venture Investments
Source recordedSEC filing: $25M sold, first sale Jun 2024
Founders and team
From 858 Therapeutics's own website: 2 on the team.
Everyone who backed them
Alexandria Venture InvestmentsVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about 858 Therapeutics
How much has 858 Therapeutics raised?
858 Therapeutics has raised $50M across 1 round since 2024.
When did 858 Therapeutics last raise?
858 Therapeutics's most recent round was a Series B of $50M in Sept 2024.
What was 858 Therapeutics's biggest round?
Its most recent round, $50M in Sept 2024, is also its largest on record.
Who backed 858 Therapeutics first?
858 Therapeutics's first round on record, in Sept 2024, was backed by New Enterprise Associates, Insight Partners and Versant Ventures and 2 others.
What stage is 858 Therapeutics at?
858 Therapeutics's latest named round is a Series B, in Sept 2024.
Where is 858 Therapeutics based?
858 Therapeutics is based in the United States.
Companies like 858 Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.